Stay updated on M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check47 days agoChange DetectedThe webpage has removed significant background information about pancreatic cancer and the investigational drug M7824, while adding a new version number and a reference to a study location.SummaryDifference42%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check90 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.